Diabetic retinopathy detection is the process of identifying and diagnosing the growth of abnormal blood vessels and damage in the retina due to high blood sugar from diabetes, using deep learning techniques.
Diabetic Macular Edema (DME) is a leading cause of vision loss among patients with Diabetic Retinopathy (DR). While deep learning has shown promising results for automatically detecting this condition from fundus images, its application remains challenging due the limited availability of annotated data. Foundation Models (FM) have emerged as an alternative solution. However, it is unclear if they can cope with DME detection in particular. In this paper, we systematically compare different FM and standard transfer learning approaches for this task. Specifically, we compare the two most popular FM for retinal images--RETFound and FLAIR--and an EfficientNet-B0 backbone, across different training regimes and evaluation settings in IDRiD, MESSIDOR-2 and OCT-and-Eye-Fundus-Images (OEFI). Results show that despite their scale, FM do not consistently outperform fine-tuned CNNs in this task. In particular, an EfficientNet-B0 ranked first or second in terms of area under the ROC and precision/recall curves in most evaluation settings, with RETFound only showing promising results in OEFI. FLAIR, on the other hand, demonstrated competitive zero-shot performance, achieving notable AUC-PR scores when prompted appropriately. These findings reveal that FM might not be a good tool for fine-grained ophthalmic tasks such as DME detection even after fine-tuning, suggesting that lightweight CNNs remain strong baselines in data-scarce environments.
Diabetic retinopathy (DR) is a leading cause of blindness worldwide, and AI systems can expand access to fundus photography screening. Current FDA-cleared systems primarily provide binary referral outputs, where this minimal output may limit clinical trust and utility. Yet, determining the most effective output format to enhance clinician-AI performance is an empirical challenge that is difficult to assess at scale. We evaluated multimodal large language models (MLLMs) for DR detection and their ability to simulate clinical AI assistance across different output types. Two models were tested on IDRiD and Messidor-2: GPT-4o, a general-purpose MLLM, and MedGemma, an open-source medical model. Experiments included: (1) baseline evaluation, (2) simulated AI assistance with synthetic predictions, and (3) actual AI-to-AI collaboration where GPT-4o incorporated MedGemma outputs. MedGemma outperformed GPT-4o at baseline, achieving higher sensitivity and AUROC, while GPT-4o showed near-perfect specificity but low sensitivity. Both models adjusted predictions based on simulated AI inputs, but GPT-4o's performance collapsed with incorrect ones, whereas MedGemma remained more stable. In actual collaboration, GPT-4o achieved strong results when guided by MedGemma's descriptive outputs, even without direct image access (AUROC up to 0.96). These findings suggest MLLMs may improve DR screening pipelines and serve as scalable simulators for studying clinical AI assistance across varying output configurations. Open, lightweight models such as MedGemma may be especially valuable in low-resource settings, while descriptive outputs could enhance explainability and clinician trust in clinical workflows.
Diabetic Retinopathy (DR) is a major cause of global blindness, necessitating early and accurate diagnosis. While deep learning models have shown promise in DR detection, their black-box nature often hinders clinical adoption due to a lack of transparency and interpretability. To address this, we propose XDR-LVLM (eXplainable Diabetic Retinopathy Diagnosis with LVLM), a novel framework that leverages Vision-Language Large Models (LVLMs) for high-precision DR diagnosis coupled with natural language-based explanations. XDR-LVLM integrates a specialized Medical Vision Encoder, an LVLM Core, and employs Multi-task Prompt Engineering and Multi-stage Fine-tuning to deeply understand pathological features within fundus images and generate comprehensive diagnostic reports. These reports explicitly include DR severity grading, identification of key pathological concepts (e.g., hemorrhages, exudates, microaneurysms), and detailed explanations linking observed features to the diagnosis. Extensive experiments on the Diabetic Retinopathy (DDR) dataset demonstrate that XDR-LVLM achieves state-of-the-art performance, with a Balanced Accuracy of 84.55% and an F1 Score of 79.92% for disease diagnosis, and superior results for concept detection (77.95% BACC, 66.88% F1). Furthermore, human evaluations confirm the high fluency, accuracy, and clinical utility of the generated explanations, showcasing XDR-LVLM's ability to bridge the gap between automated diagnosis and clinical needs by providing robust and interpretable insights.
Diabetic Retinopathy (DR) is a leading cause of vision loss in working-age individuals. Early detection of DR can reduce the risk of vision loss by up to 95%, but a shortage of retinologists and challenges in timely examination complicate detection. Artificial Intelligence (AI) models using retinal fundus photographs (RFPs) offer a promising solution. However, adoption in clinical settings is hindered by low-quality data and biases that may lead AI systems to learn unintended features. To address these challenges, we developed RAIS-DR, a Responsible AI System for DR screening that incorporates ethical principles across the AI lifecycle. RAIS-DR integrates efficient convolutional models for preprocessing, quality assessment, and three specialized DR classification models. We evaluated RAIS-DR against the FDA-approved EyeArt system on a local dataset of 1,046 patients, unseen by both systems. RAIS-DR demonstrated significant improvements, with F1 scores increasing by 5-12%, accuracy by 6-19%, and specificity by 10-20%. Additionally, fairness metrics such as Disparate Impact and Equal Opportunity Difference indicated equitable performance across demographic subgroups, underscoring RAIS-DR's potential to reduce healthcare disparities. These results highlight RAIS-DR as a robust and ethically aligned solution for DR screening in clinical settings. The code, weights of RAIS-DR are available at https://gitlab.com/inteligencia-gubernamental-jalisco/jalisco-retinopathy with RAIL.
The analysis of fundus images is critical for the early detection and diagnosis of retinal diseases such as Diabetic Retinopathy (DR), Glaucoma, and Age-related Macular Degeneration (AMD). Traditional diagnostic workflows, however, often depend on manual interpretation and are both time- and resource-intensive. To address these limitations, we propose an automated and interpretable clinical decision support framework based on a hybrid feature extraction model called HOG-CNN. Our key contribution lies in the integration of handcrafted Histogram of Oriented Gradients (HOG) features with deep convolutional neural network (CNN) representations. This fusion enables our model to capture both local texture patterns and high-level semantic features from retinal fundus images. We evaluated our model on three public benchmark datasets: APTOS 2019 (for binary and multiclass DR classification), ORIGA (for Glaucoma detection), and IC-AMD (for AMD diagnosis); HOG-CNN demonstrates consistently high performance. It achieves 98.5\% accuracy and 99.2 AUC for binary DR classification, and 94.2 AUC for five-class DR classification. On the IC-AMD dataset, it attains 92.8\% accuracy, 94.8\% precision, and 94.5 AUC, outperforming several state-of-the-art models. For Glaucoma detection on ORIGA, our model achieves 83.9\% accuracy and 87.2 AUC, showing competitive performance despite dataset limitations. We show, through comprehensive appendix studies, the complementary strength of combining HOG and CNN features. The model's lightweight and interpretable design makes it particularly suitable for deployment in resource-constrained clinical environments. These results position HOG-CNN as a robust and scalable tool for automated retinal disease screening.
The scarcity of high-quality, labelled retinal imaging data, which presents a significant challenge in the development of machine learning models for ophthalmology, hinders progress in the field. To synthesise Colour Fundus Photographs (CFPs), existing methods primarily relying on predefined disease labels face significant limitations. However, current methods remain limited, thus failing to generate images for broader categories with diverse and fine-grained anatomical structures. To overcome these challenges, we first introduce an innovative pipeline that creates a large-scale, synthetic Caption-CFP dataset comprising 1.4 million entries, called RetinaLogos-1400k. Specifically, RetinaLogos-1400k uses large language models (LLMs) to describe retinal conditions and key structures, such as optic disc configuration, vascular distribution, nerve fibre layers, and pathological features. Furthermore, based on this dataset, we employ a novel three-step training framework, called RetinaLogos, which enables fine-grained semantic control over retinal images and accurately captures different stages of disease progression, subtle anatomical variations, and specific lesion types. Extensive experiments demonstrate state-of-the-art performance across multiple datasets, with 62.07% of text-driven synthetic images indistinguishable from real ones by ophthalmologists. Moreover, the synthetic data improves accuracy by 10%-25% in diabetic retinopathy grading and glaucoma detection, thereby providing a scalable solution to augment ophthalmic datasets.
Diabetic retinopathy is a severe eye condition caused by diabetes where the retinal blood vessels get damaged and can lead to vision loss and blindness if not treated. Early and accurate detection is key to intervention and stopping the disease progressing. For addressing this disease properly, this paper presents a comprehensive approach for automated diabetic retinopathy detection by proposing a new hybrid deep learning model called VR-FuseNet. Diabetic retinopathy is a major eye disease and leading cause of blindness especially among diabetic patients so accurate and efficient automated detection methods are required. To address the limitations of existing methods including dataset imbalance, diversity and generalization issues this paper presents a hybrid dataset created from five publicly available diabetic retinopathy datasets. Essential preprocessing techniques such as SMOTE for class balancing and CLAHE for image enhancement are applied systematically to the dataset to improve the robustness and generalizability of the dataset. The proposed VR-FuseNet model combines the strengths of two state-of-the-art convolutional neural networks, VGG19 which captures fine-grained spatial features and ResNet50V2 which is known for its deep hierarchical feature extraction. This fusion improves the diagnostic performance and achieves an accuracy of 91.824%. The model outperforms individual architectures on all performance metrics demonstrating the effectiveness of hybrid feature extraction in Diabetic Retinopathy classification tasks. To make the proposed model more clinically useful and interpretable this paper incorporates multiple XAI techniques. These techniques generate visual explanations that clearly indicate the retinal features affecting the model's prediction such as microaneurysms, hemorrhages and exudates so that clinicians can interpret and validate.
Diabetic retinopathy (DR) is one of the major complications in diabetic patients' eyes, potentially leading to permanent blindness if not detected timely. This study aims to evaluate the accuracy of artificial intelligence (AI) in diagnosing DR. The method employed is the Synthetic Minority Over-sampling Technique (SMOTE) algorithm, applied to identify DR and its severity stages from fundus images using the public dataset "APTOS 2019 Blindness Detection." Literature was reviewed via ScienceDirect, ResearchGate, Google Scholar, and IEEE Xplore. Classification results using Convolutional Neural Network (CNN) showed the best performance for the binary classes normal (0) and DR (1) with an accuracy of 99.55%, precision of 99.54%, recall of 99.54%, and F1-score of 99.54%. For the multiclass classification No_DR (0), Mild (1), Moderate (2), Severe (3), Proliferate_DR (4), the accuracy was 95.26%, precision 95.26%, recall 95.17%, and F1-score 95.23%. Evaluation using the confusion matrix yielded results of 99.68% for binary classification and 96.65% for multiclass. This study highlights the significant potential in enhancing the accuracy of DR diagnosis compared to traditional human analysis
Diabetic retinopathy is a serious ocular complication that poses a significant threat to patients' vision and overall health. Early detection and accurate grading are essential to prevent vision loss. Current automatic grading methods rely heavily on deep learning applied to retinal fundus images, but the complex, irregular patterns of lesions in these images, which vary in shape and distribution, make it difficult to capture subtle changes. This study introduces RadFuse, a multi-representation deep learning framework that integrates non-linear RadEx-transformed sinogram images with traditional fundus images to enhance diabetic retinopathy detection and grading. Our RadEx transformation, an optimized non-linear extension of the Radon transform, generates sinogram representations to capture complex retinal lesion patterns. By leveraging both spatial and transformed domain information, RadFuse enriches the feature set available to deep learning models, improving the differentiation of severity levels. We conducted extensive experiments on two benchmark datasets, APTOS-2019 and DDR, using three convolutional neural networks (CNNs): ResNeXt-50, MobileNetV2, and VGG19. RadFuse showed significant improvements over fundus-image-only models across all three CNN architectures and outperformed state-of-the-art methods on both datasets. For severity grading across five stages, RadFuse achieved a quadratic weighted kappa of 93.24%, an accuracy of 87.07%, and an F1-score of 87.17%. In binary classification between healthy and diabetic retinopathy cases, the method reached an accuracy of 99.09%, precision of 98.58%, and recall of 99.6%, surpassing previously established models. These results demonstrate RadFuse's capacity to capture complex non-linear features, advancing diabetic retinopathy classification and promoting the integration of advanced mathematical transforms in medical image analysis.
Multi-view diabetic retinopathy (DR) detection has recently emerged as a promising method to address the issue of incomplete lesions faced by single-view DR. However, it is still challenging due to the variable sizes and scattered locations of lesions. Furthermore, existing multi-view DR methods typically merge multiple views without considering the correlations and redundancies of lesion information across them. Therefore, we propose a novel method to overcome the challenges of difficult lesion information learning and inadequate multi-view fusion. Specifically, we introduce a two-branch network to obtain both local lesion features and their global dependencies. The high-frequency component of the wavelet transform is used to exploit lesion edge information, which is then enhanced by global semantic to facilitate difficult lesion learning. Additionally, we present a cross-view fusion module to improve multi-view fusion and reduce redundancy. Experimental results on large public datasets demonstrate the effectiveness of our method. The code is open sourced on https://github.com/HuYongting/WGLIN.